Does additional HIPEC help after CRS in peritoneal disseminated gastric cancer?

Pubblicato online: 09 mar 2018

Pagine: 187 - 189

Ricevuto: 29 set 2017

Accettato: 29 dic 2017

DOI: https://doi.org/10.1515/cipms-2017-0035

Parole chiave

gastric adenocarcinoma, hyperthermic intraperitoneal chemotherapy (HIPEC), peritoneal metastasis, peritoneal carcinomatosis, GASTRIPEC trial

© 2017 Beate Rau et al., published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.